학술논문
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
Document Type
Article
Author
Kraynyak, K.A.; Blackwood, E.; Agnes, J.; Giffear, M.; Amante, D.; Christensen-Quick, A.; Liu, N.; Andrade, V.M.; Diehl, M.C.; Wani, S.; Lupicka, M.; Sylvester, A.; Morrow, M.P.; Pezzoli, P.; McMullan, T.; Smith, T.R.F.; Ramos, S.J.; Lee, J.; Dallas, M.; Shah Brown, A.; Shea, J.E.; Kim, J.J.; Broderick, K.E.; Humeau, L.M.; Boyer, J.D.; Mammen, M.P.; Tebas, P.; Reuschel, E.L.; Purwar, M.; Kulkarni, A.J.; Zaidi, F.I.; Frase, D.; Liaw, K.; Weiner, D.B.; Ervin, J.; Adams, M.
Source
In: Journal of Infectious Diseases . (Journal of Infectious Diseases, 1 June 2022, 225(11):1923-1932)
Subject
Language
English
ISSN
15376613
00221899
00221899